Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Also, from another poster.
From GT news. GT is also in advanced discussions with a number of high-end, commercially successful out-of-state brands to serve as their white label producer for entry into the Missouri market.
Is that fact or an opinion? If fact pls link.
In regards GT and ALPS, keep in mind ALPS has clients which are also partners, I'll recommend you look into that for details.
That being said, Australis will get GT products to then sell it to the acquired partners from ALPS, so then partners/ clients sell it to the market.
So 4 birds in one shoot, GT products, ALPS products, ALPS clients, ALPS partners. That ends with a very healthy business ecosystem if you ask me. Very smart move. That will nitro the revenue in a hard bit very soon. That seems the start, then the expansion with more prob partners (Aurora?) And prob key acquisitions to supplement the ecosystem.
Yo Bubba
Feeling like you struck gold buddy?
GLTU
Unfortunately for Ausaf Aurora is going with Reliva LLC as their doorway into US
Thanks for reply GLTU
BubbaInSC, yeah, I've been debating whether or not to park more money here at this stage. I'm tempted, but then again I want to wait and see.
Is it going to run up on Booth's involvement, only to fade again? Or is it going to be a sustainable move with substance behind it? So far they've had very little revenue and HUGE losses each quarter. I'm sure the lawsuit had an impact on expenses. Hiring a bunch of lawyers to fight lawsuits certainly must have been a drain on the bottom line. Now that Green Therapeutics and AUSA have kissed and made up, at least those expenses go away now. Hopefully like they indicate, this merger will be accretive and we'll start to see some decent revenues. If not, then the share price will sink back down to around a dime again.
Regarding your question about "how Australis can control the type and quality of MJ strains when they're going to be building greenhouses for other companies...and not for Australis," I'm not sure that's their main objective right now. It sounds to me like they want to build out grow space and to sell to others as a producer for white label cannabis. In other words they want to become a wholesaler of product, and grow house consultant.
I don't know, I'm kind of with you. It seems like during this past year the US MSO's have gotten the jump and it's going to be difficult to catch up. But at least AUSAF is back to focusing on cannabis and derivatives, and ALP consulting vs. the previous leadership who were more focused on software and kiosks/atms. I didn't understand why they were focusing on that before, except that Scott Dowty was from the gaming industry and so he was trying to leverage his gaming security and technology knowledge. To me it seemed unfocused and not part of the core thesis of what AUSAF was supposed to be about.
From the beginning, the spin-off was supposed to be a "beachfront into the US markets" that Aurora would eventually either fold into the larger entity, so when AUSAF veered off into kiosks and ATMS I think they lost their focus.
Hope fully Terry will be using Australis to redeem his reputation, and hopefully his "cap-ex light" model will be more successful than Aurora's "pay any price, and write it down later" business model, that bit them in the a$$.
Time will tell. I'm watching CLOSELY.
Booth_Says_"Not_an_Aurora_2.0"
He will either be a hero....or a goat a second time.
This looks like the beginning of the second wave for Canadian MJ stocks, but those MJ stocks who already have a footprint in USA are ahead in the game and have been increasing since April 2020.
Seems they're trying to emphasize the low CapEx term to address overpaying for assets and large goodwill writeoffs for losses for many Canadien MJ stocks; like Aurora.
ALPS is fine, but not sure of their presence in USA. Indoor grows for boutique type mj strains is fine. Not sure how Australis can control the type and quality of MJ strains when they're going to be building greenhouses for other companies...and not for Australis.
And, not that the Green Therapeutics branding of products is good/bad....just never heard of their brands. Same thing though, does Green Therapeutics have a footprint anywhere in USA right now?
Not quite ready to dip toes in this stock as others are more attractive.
At the very minimum, pps may increase this month as part of a lagging response to overall mj price movement to the upside.
Thoughts?
1/8/21
https://cheddar.com/media/cannabis-firm-australis-not-aurora-terry-booth#:~:text=SHOP-,Cannabis%20Firm%20Australis%20Capital%20Is%20'Not%20an%20Aurora%202.0%2C',New%20CEO%20Terry%20Booth%20Says&text=After%20a%20bitter%20proxy%20battle,owned%20by%20the%20Edmonton%20producer.&text=ALPS%2C%22%20Booth%20said.
TB so far so good. Getting $AUSAF two acquisitions, ALPS and Green Therapeutics. Plan is to get ALPS products and clients/partners to sell thru them Green Therapeutics products. Clever move to get this started and running on nitro. Once this acquisitions are completed SP will move up. Also, once we have more news from government on the marihuana sector, more SP appreciation. Once the last 2 are fulfilled $ACB will get on the play since they own warrants on $AUSAF. According to $ACB that is the plan. That is not counting on uplisting once fins come green sooner than later. Once there, short should show. No point on shorting or selling, price will go up with these catalysts and they will burn.
BubbaInSC that's a good question. In the conference call he implied he was responsible for all the good things that happened at Aurora, and he led it to become a 4.2 billion company, and now it's a 2.2 company, but that all happened after he "retired" (AKA was ejected). He actually used that term in his conf call. He admitted he was removed. SOoooo, makes you wonder... if he was such an asset why did they get rid of him?
Hopefully at ACB he learned all the right things to do (and the things NOT to do) the second time around. Hopefully he's learned from his mistakes and won't make the same missteps at Australis.
We'll see. Time will tell. So far the market is reacting well. Hopefully this is a sustained move upward, and not just a temporary MOMO thing.
Liking the first impression
Is Booth Gonna Be Good or Bad? 2 Acquisitions
1/5/21 https://www.newswire.ca/news-releases/australis-enters-into-term-sheet-to-acquire-alps-866142013.html
So far so good
GLTU mate
Well I hope you're right and this is the new normal, because I could SERIOUSLY get used to this! Woo hoo!!
I believe we will see a continued upward trend
With Democrats in office and presumably Safe Banking Act passing; well high tide raises all boats
But we shall see
GLTU
Wow, apparently Terry Booth coming on board is having a HUGE impact on the stock price. Yesterday we were up 37% on 4,000 times the avg daily volume and today we're up another 44% on 1,200 times the avg daily volume.
I wonder if this is a temporary blip, or if it will continue?
Well jp we’re going to find out about Terry Booth now as CEO
I’m holding my position
GLTU
Just read they made 2 potential acquisitions! Not sure if that’s why there wasn’t any trading today though
Damn. Had been thinking of buying more in the last few days
Anxious to learn more
Was Australis halted? The volume today is ZERO.
Do you still plan on loading in the 10’s?
Thanks for update
Well perhaps they will bring in a competent CEO?
Still holding as well. Be nice if it turns in our favor
GLTU
Still here. Still holding all my shares and waiting. Almost no news. Booth and crew did take over.
TORONTO, Nov. 18, 2020 /PRNewswire via COMTEX/ -- TORONTO, Nov. 18, 2020 /PRNewswire/ - Australis Capital Inc. ("AUSA" or the "Company") (CSE: AUSA) is pleased to announce the results of its annual and special meeting of shareholders held earlier today (the "Meeting") at which approximately 58.8% of the issued and outstanding shares were represented. Prior to the Meeting the director nominees proposed by AUSA agreed not to stand for election such that the board of directors was fixed at five and each of the nominees of AUSA concerned shareholders, were duly elected at the Meeting. As a result Dr. Duke Fu, Dr. Jason Dyck, Mr. Avi Geller, Mr. Hanoz Kapadia and Mr. John Esteireiro will serve as directors of the Company until the next annual meeting of shareholders or until they otherwise cease to hold office. Full details and backgrounds regarding each of the directors can be reviewed in the proxy circular prepared on behalf of the Concerned Shareholders which was filed on SEDAR on October 16, 2020.
Dr. Duke Fu commented "We are pleased that the efforts of board renewal are now complete, and have received such overwhelming support of the Australis shareholders. We have significant work ahead of us to implement our plan for the Company to become a leading US cannabis company. We look forward to great things for Australis in the future. We thank all shareholders for their involvement, support and patience during this process. Our mission to move the Company forward is front and centre".
"Speaking for all of the Concerned Shareholders, we are very excited about the future of AUSA," commented Concerned Shareholder Terry Booth. "The Concerned Shareholders have been working diligently together to advance a number of potential opportunities which we will now introduce to the refreshed board. The Company can now take steps to implement the "trojan horse" low CapEx strategy we've been working on for months". Booth further commented "AUSA shareholders have spoken, with stunning support for the Concerned Shareholders' initiatives and the new board. Our shareholders expect this new board and the new management to execute. There is simply no alternative, shareholders expect and deserve accretive growth without delay. It is indeed time to ignite, excite and delight this loyal shareholder base".
Detailed results of the ballot vote on the election of directors are set forth below:
NOMINEE
FOR
% FOR
WITHHELD
% WITHHELD
Dr. Duke Fu
67,976,337
95.30%
3,205,619
4.70%
Dr. Jason Dyck
65,011,595
95.35%
3,170,362
4.65%
Avi Geller
65,005,512
95.34%
3,178,827
4.66%
Hanoz Kapadia
65,003,096
95.34
3,175,844
4.66%
John Esteireiro
65,004,882
95.34%
3,176,472
4.66%
In addition, shareholders of the Company also approved resolutions appointing Baker Tilly LLP as the auditor of the Company for the ensuing year, changing the name of the Corporation to AUSA Corporation, or such other name acceptable to the board of directors, and approving an amendment to the Company's by-laws to provide that meetings of shareholders may be held entirely virtually. Resolutions approving the Company's stock option plan, restricted share unit plan and proposed continuance to British Columbia were each defeated.
As expected, Harry DeMott, Chief Executive Officer, Alex Han, Chief Financial Officer, Cleve Tzung, Chief Operating Officer and Daniel Norr, Executive Vice President and Chief Legal Officer tendered their resignations as officers of the Company each individual chose their respective resignations to be effective as of December 18, 2020. The newly elected directors of the Company appointed Dr. Duke Fu as Interim Chief Executive Officer of the Company and have commenced an expedient executive search for a permanent experienced Chief Executive Officer and a permanent experienced Chief Financial Officer.
The board of directors of the Company have also retained Terry Booth, one of the concerned shareholders and an experienced leader in the cannabis industry as a consultant to provide strategic advice to the Company.
About Australis Capital Inc.
AUSA invests in, operates and builds differentiated companies primarily in the cannabis industry. AUSA's assets include investments in Cocoon, Body and Mind Inc., Quality Green, and Folium Biosciences.
The Company's Common shares trade on the CSE under the symbol "AUSA" and on the OTCQB under the symbol "AUSAF".
For further information about AUSA, please visit the website at ausa-corp.com or contact the Company by e-mail at ir@ausa-corp.com.
Damn it! Only 1.3% today But on second thought more than treasuries after a year
Good luck to every-one on this board
Cha-Ching! Here we go again. Up 31%
Would have never guessed this would be my largest moneymaker. And the crowds haven’t caught on
Oh, but they will
GLTA
Thanks mate
Certainly will not vote for him. Will sit on sidelines watching developments
I would not call taking a company from .34 to over $10 in a few years a failure. The failure was he went too big too fast now ACB grows too much cannabis and cannot sell it all. If nothing else it will be a great short
He was successful at taking all investors money. Him and Cam both. Cam I believed in, Terry I never had faith in at all. Whenever he spoke it was an embarrassment. Showed up to Vegas drunk and spewing profanity at a conference and made an ass of himself. Said “Big Booze” on CNBC like a crusty pirate. I was lucky to get out of ACB for a small profit after being up huge in 2018... Feel bad for everyone Terry screwed in Aurora now. Both of their departures smell bad and now they are unheard of counting their millions while the business they created flounders... They didn’t have the skills to run a business and had “green fever” overbuilding for global domination, when all they really had was 1/10th of a Canadian marketplace. If he has any plans to get involved with Australis, I’d run for the hills...
But all I know about Booth is that he was a failure at Aurora? No?
If Booth pulls off a takeover I will load up under .10
https://money.tmx.com/en/quote/AUSA:CNX/news/5572870060980747/Australis_Shareholders_Have_Suffered_Long_Enough_The_Concerned_Shareholders_of_AUSTRALIS_file_and_Mail_Proxy_Circular_and_Urge_Shareholders_to_Vote_for_positive_change_using_the_Yellow_Proxy
Thanks
Think I will wait a bit to invest more. My DD shows Rev’s of only 160k per year and losing significant money
No just what i posted. This company went dark it is my understanding that they are acquiring US cannabis companies and licenses but I have not done any DD.
Do you have any inside skinny mate?
Looks like Terry Booth is trying to make this his own personal piggy bank like ACB
https://money.tmx.com/en/quote/AUSA:CNX/news/5891261101296671/C_O_R_R_E_C_T_I_O_N_from_Source_Australis_Capital_Inc
This was lost in the shuffle everyone forgot about it.
Did anyone get a chance to listen in on the conference call? Is there a replay number?
What in this sector isn’t shit? Hold tight me friend, these are the dark days. IT WILL get better just not right now.
For real lol
omg just seeing this... wtf-
Australis Capital Announces Termination of Merger Agreement with Folium Biosciences
1:00 pm ET February 18, 2020 (PR Newswire) Print
Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA" or the "Company") previously announced on, December 11, 2019, a proposed merger by and among AUSA, Folium Equity Holding LLC ("Folium") and Folium Merger Sub, LLC by which Folium would become a wholly owned subsidiary of AUSA, and AUSA would be rebranded as and carry on the business of Folium. AUSA recently discovered new relevant information with regard to Folium and, on that basis, AUSA has decided to not proceed with the merger.
https://mma.prnewswire.com/media/1091023/Australis_Capital_Inc__Australis_Capital_Announces_Termination_o.jpg
"AUSA continues to lean heavily on corporate governance and our vision to navigate through an incredibly unpredictable market over the past 12 months," states Scott Dowty, CEO of AUSA. "With over $38.2 million in cash, liquid assets, and other assets that can easily be converted into cash within a short amount of time and $5.2 million annual burn excluding charges from capital projects and one-time occurrence, AUSA has a very strong financial position. With 18 months of operating experience behind us, we are excited about the future and eager to execute on our strategy starting with our corporate update on February 26, 2020."
A trading halt on AUSA stock was issued in accordance with the policies of the Canadian Stock Exchange ("CSE") at the time of the announcement of the proposed merger agreement. As the transaction will not proceed, trading is expected to resume on the CSE and OTC shortly.
AUSA is hosting a corporate update call at 1:00 PM EST on Wednesday, February 26, 2020. The conference call may be accessed by dialing 1.888.396.8094 (Toll-Free North America) or 1.416.764.8649 (Canada).
About Australis Capital Inc.AUSA operates and builds transformative, differentiated cannabis companies predominantly in the United States, a highly-regulated, fragmented, and rapidly expanding industry. AUSA adheres to stringent evaluation and operating criteria focusing on high-quality opportunities while maintaining a steadfast commitment to governance and community. AUSA's Board and management team have material experience with, and knowledge of, the cannabis space in the U.S., extensive backgrounds in highly-regulated industries and regulatory compliance. AUSA operating and portfolio assets include Rthm Technologies Inc., Body and Mind Inc., Quality Green Inc., Mr. Natural Inc., Green Therapeutics, LLC., and Cocoon Technology LLC.
The Company's Common shares trade on the CSE under the symbol "AUSA" and on the OTCQX under the symbol "AUSAF".
For further information about AUSA, please visit the website at ausa-corp.com or contact the Company by e-mail at ir@ausa-corp.com.
ON BEHALF OF THE BOARD OF DIRECTORS
"Scott Dowty"
________________________________Scott DowtyChief Executive Officer
Forward-Looking Information Statement
This news release contains statements and information that, to the extent that they are not historical fact, constitute "forward-looking information" within the meaning of applicable securities legislation, including statements is respect of the AUSA shares resuming trading on the CSE. Forward-looking information is based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information. Accordingly, readers should not place undue
There is a conference call to address the rebranding and merger with Folium
Bioscience. Stay patient and check out the url :
https://finance.yahoo.com/news/australis-capital-host-conference-call-184000476.html
I'm not sure what the heck is going on. Yesterday it looked like around 1200 shares traded. Today ZERO. My TDAmeritrade shows a bid of .05 and ask of .85 so doesn't look like it's unhalted yet.
But what shennanigans were happening yesterday??
sure looks like it to me. am seeing a different pps now. Heck we're LIVE!
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
226
|
Created
|
10/02/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |